Drug of Abuse (DOA)
THC (Marijuana) Rapid Test
Detects Δ9-THC-COOH. colloidal-gold. Specimen: Urine.
| Target / Analyte | Δ9-THC-COOH |
|---|---|
| Disease / Indication | Drug screening |
| Series | Drug of Abuse (DOA) |
| Method | colloidal-gold |
| Specimen | Urine |
| Regulatory | CE · FDA |
| OEM/ODM | Available — private label & custom panel |
Direct Answer
This rapid test detects Δ9-THC-COOH in Urine to support Drug screening. It is a colloidal-gold screening test — a reactive result is presumptive and should be confirmed per the intended use.
Intended Use
Detection of Δ9-THC-COOH (cannabis metabolite) in urine for drug screening.
Clinical Context
Workplace and clinical drug-of-abuse screening. Cut-off typically 50 ng/mL.
Test Principle
Colloidal-gold immunochromatography (lateral flow). The device captures the target analyte (antigen or antibody) on a membrane via labeled antibodies, producing a visible test line within minutes. Qualitative or semi-quantitative, intended as a screening/triage aid — not a replacement for confirmatory laboratory testing.
Limitations
Screening result — presumptive positive requires confirmatory (GC-MS/LC-MS).
Procurement
Specimen: urine. Format: cassette / dipstick / panel. CE-marked line (FDA status per product on request).
Interpretation
| Result | Lines | Meaning |
|---|---|---|
| Positive | Test + control line | Target detected (presumptive positive) |
| Negative | Control line only | Below cut-off / not detected |
| Invalid | No control line | Repeat with a new device |
Documentation & quotation — datasheet, IFU, MOQ and OEM/ODM options on request.
Last reviewed: 2026-09-12